-Tehelka With 65 percent of the population below the age of 35, India boasts of an unparalleled generational dividend, but are we turning this potential into a disaster? Avalok Langer spots a ticking time bomb Nutrition & Health* 40% of children in India are malnourished 43% of children in the age group of 12-23 months receive full immunisation 48%+ of children are underweight 50%+ of all deaths under age 5 are related to malnutrition 45% of children...

-The Hindu THIRUVANANTHAPURAM: Dengue, the world's most rapidly spreading mosquito-borne viral disease, is taking a far bigger human toll than was believed to be the case. As many as 390 million people across the globe could be falling victim to the virus each year, according to a multinational study published by Nature on Sunday. India emerges in the analysis as the country with the world's highest dengue burden, with about 34 per...

-The Hindu   Entering third polio-free year, India must destroy all wild poliovirus lab samples by December Having successfully completed two polio-free years, India is preparing to receive the crucial polio eradication certificate from the World Health Organisation (WHO). The certificate is issued on completion of incident-free three years. This primarily involves the destruction or safe storage of all laboratory sources of wild poliovirus. The storage should be in laboratories that meet international standards...

-The Hindustan Times Cancer drugs will cost almost 25% less if the regulator implements a new formula that calls for a price cap. The price regulator National Pharmaceutical Pricing Authority (NPPA) is considering a pricing mechanism similar to the one for insulin products - which has brought down prices by up to 40% - for 33 cancer drugs, most of them generics. Basically, the lowest price from the list of drugs in a...

-The Hindu Well before the Supreme Court rejected Novartis' application for patent for Glivec (Gleevec in the U.S.), drawing attention to the dichotomy of generic and patented drugs, activists have been demanding access to expensive drugs used in the treatment of cancer, hepatitis C and serious HIV. Trastuzumab is one such, used in the treatment of HER2+ type of breast cancer, which affects about one in four patients with the disease. Rough...